Crisaborole may Sustain Effective Control in Atopic Dermatitis, finds study
Managing atopic dermatitis (AD) often proves to be a persistent challenge in dermatological practice, with treatments frequently falling short in pr…
Lorem Ipsum has been the industry's standard dummy text.
Managing atopic dermatitis (AD) often proves to be a persistent challenge in dermatological practice, with treatments frequently falling short in pr…
USA: As cancer treatment advances, so do strategies to manage its side effects. A new frontier in supportive care has emerged with high-dose oral vi…
Taiwan: In a groundbreaking hospital-based study, researchers have unveiled a potentially overlooked factor in the prognosis of stroke patients: low…
According to Phase 2 results, KP104 exhibits optimal long-term safety and efficacy for complement inhibitor-naïve patients with paroxysmal nocturnal…
Researchers at the University of Michigan are finding that many patients may be encountering significant barriers to cancer care, even from their fi…
India: Melasma, a common skin condition characterized by dark patches on the face, has long troubled dermatologists and patients alike. Despite nume…
Hong Kong: In a comprehensive investigation, a recent systematic review has delved into the effect of antiresorptive drugs on osseointegrated dental…
Lorem Ipsum is simply dummy text of the printing and typesetting has been the industry's.